Share the Tech If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
Katy Athersuch NewLink sat back and profited, the same vaccine is still not registered today and must be used under clinical trial conditions. @CEPIvaccines your policy needs teeth if you are to avoid the same mistakes. #TellCEPI twitter.com/MSF_access/sta… 20:25 - 06 Mar 2019